3635 results for «2000»
3635 results
Latest topics of mitral valve interventions
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn all about the latest topics regarding mitral valve interventions: long-term outcomes after MitraClip for functional vs. degenerative mitral regurgitation, feasibility of electric cardioversion immediately after transcatheter percutaneous edge-to-edge mitral repair, and more!
TAVI and mitral interventions
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover challenging TAVI and mitral interventions, such as: bioprosthetic valve fracture, concomitant off-pump beating heart mitral repair and LAA closure, annulus rupture immediately after balloon-expandable transcatheter heart valve implantation, and more!
Excellent abstracts from Japan
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session in English and Japanese to learn more about various TAVI studies and cases, regarding topics such as comparison between self- and balloon- expandable valve, clinical outcomes of the 20mm SAPIEN 3, single proglide vascular preclose technique, and more!
PCR Tokyo Valves 2019 Opening Ceremony
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of PCR Tokyo Valves 2019 Opening Ceremony, a course which is expanding to become the major Asian forum in valvular interventions.
A novel approach to left atrial appendage occlusion (when Watchman/Amulet won’t fit!)
06 Apr 2022
See the case of a 76-year-old female patient with mitral valve repair 10 years prior found to have incomplete surgically ligated left atrial appendage, who was referred for closure.
Author
Author
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Dynamx bioadaptor restores rotational motion and vessel stress reduction in new study
02 Jun 2022
FIRE1 raises $25M to revolutionize heart failure home monitoring
15 Mar 2023
Robocath performs world’s First-In-Human remote robotic coronary angioplasty between two Chinese cities 1,700 miles apart
14 Dec 2023
Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System
15 Feb 2022
Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data
19 Sep 2022
Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.
Author
SWEDEHEART: Improving the quality of cardiology care in Sweden and beyond!
22 May 2025
Lars Wallentin and Stefan James received the Andreas Grüntzig Ethica Award during EuroPCR 2025, on behalf of a wider team of cardiovascular registry experts who have contributed in an extraordinary way to the PCR mission.
Critical reflection on effective life-long learning – interventional cardiologists in pandemic times
17 Dec 2020
Because of the current COVID-19 environment with an exponential development of ‘digital format of postgraduate learning events’, often on the same topics, it seems essential to remember the foundation of effective post graduate learning in the field of medicine, and how we...
Editorial - The “Interventional cardiac surgeon”: the (new) member of the interventional Heart Team
18 Nov 2020
Surgeons have been for many years the only interventionalists. The only “doctors” to dare enter the body and mechanically intervene on structures to cure or improve quality of life. The link between surgeons and interventional cardiologists is very strong. Many surgeons contributed to the development of...
Author
Author
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
